Stay updated on Alirocumab Vascular Effects in AMI Clinical Trial
Sign up to get notified when there's something new on the Alirocumab Vascular Effects in AMI Clinical Trial page.
Latest updates to the Alirocumab Vascular Effects in AMI Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.3.4 was added to the study record versions, replacing the previous v3.3.3 entry.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter updates remove the HHS Vulnerability Disclosure link and add Revision: v3.3.3 (replacing v3.3.2); core study information and page functionality remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check53 days agoChange DetectedMinor UI revision: the page now shows a Revision: v3.3.2 instead of the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check60 days agoChange DetectedRemoved the government funding lapse notice and its operating-status guidance from the page.SummaryDifference0.7%
- Check74 days agoChange DetectedNo substantive updates were detected; the study record content and status appear unchanged, with only minor UI/visual adjustments between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check103 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous version v3.1.0.SummaryDifference12%
Stay in the know with updates to Alirocumab Vascular Effects in AMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab Vascular Effects in AMI Clinical Trial page.